Staffan Strömberg

Staffan Strömberg

Chief Executive Officer at INFANT BACTERIAL THERAPEUTICS AB

Net worth: 750 835 $ as of 2026-07-30

59 year
Health Technology
Consumer Services
Process Industries

Profile

Staffan Strömberg is currently Chief Executive Officer at Infant Bacterial Therapeutics AB since 2013.
Current roles also include Director positions at Cycle Pharmaceuticals AB, Eteboxagu AB, and BioGaia Pharma AB, as well as Head-Medical Devices at The Medical Products Agency.
Former roles include Chief Executive Officer at Tenova Bioplastics AB from 2010 to 2012, Director at Genetic Analysis AS from 2020 to 2023, Vice President at Nicox SA from 2005 to 2009, Head-Research & Development at Swedish Orphan Biovitrum International AB from 1998 to 2002, and Head-Medical Devices at Läkemedelsverket from 2009 to 2010.
Education includes graduate and doctorate degrees from the Royal Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-24 106,910 ( 0.82% ) 750 835 $ 2026-07-30

Staffan Strömberg active positions

CompaniesPositionStart
INFANT BACTERIAL THERAPEUTICS AB Chief Executive Officer 2012-12-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -

Former positions of Staffan Strömberg

CompaniesPositionEnd
GENETIC ANALYSIS Director/Board Member 2023-11-01
Chief Executive Officer 2012-01-31
Läkemedelsverket
Corporate Officer/Principal 2010-09-30
NICOX SA Corporate Officer/Principal 2008-12-31
░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Staffan Strömberg's experience

Training of Staffan Strömberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Process Industries

Health Technology

Läkemedelsverket

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Staffan Strömberg